# Complement Therapeutics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/complement-therapeutics

- Industry: Biotechnology
- Headquarters: London, UK
- Website: www.complementtx.com
- Total disclosed funding: $85M
- Latest round: Series A (Apr 17, 2023)
- Investors on record: 7

## About

Based in London, UK, and founded in 2020 by Simon J. Clark, Paul Bishop, and Richard Unwin, Complement Therapeutics Ltd, a.k.a. CTx operates as a biotechnology company that conducts research and develops novel therapeutic approaches to address needs in diseases related to complement dysregulation through gene therapies and protein-based approaches. In February 2022, Complement Therapeutics Ltd raised EUR 5 million in seed funding from BioGeneration Ventures (BGV) and Forbion. As of February 2022, Rafiq Hasan is the CEO of Complement Therapeutics Ltd.

Complement Therapeutics Ltd is developing the next generation of complement medicines by processing new complement system insights into innovative treatments for complement-related diseases, such as age-related macular degeneration. The company has also developed a complement precision medicine (CPM) platform, a novel mass spectrometry platform that enables the measurement of more than 30 complement proteins from a systemic blood sample.

The company plans to use its proceeds from February 2022 funding to develop more therapies for patients suffering from complement-driven diseases.

## Funding rounds

- Series A, Apr 17, 2023, $79M — Seroba, Gimv, Forbion, BioGeneration Ventures, Cambridge Innovation Capital, Hadean Ventures, Panakes Partners
- Seed, Feb 23, 2022, $5.7M — Forbion, BioGeneration Ventures

## Investors

- Forbion (https://capitalatlas.ai/funds/forbion) — Seed, Series A
- BioGeneration Ventures (https://capitalatlas.ai/funds/biogeneration-ventures) — Seed, Series A
- Seroba (https://capitalatlas.ai/funds/seroba) — Series A
- Gimv (https://capitalatlas.ai/funds/gimv) — Series A
- Cambridge Innovation Capital (https://capitalatlas.ai/funds/cambridge-innovation-capital) — Series A
- Hadean Ventures (https://capitalatlas.ai/funds/hadean-ventures) — Series A
- Panakes Partners (https://capitalatlas.ai/funds/panakes-partners) — Series A